HC Wainwright & Co. Maintains Buy on Surrozen, Raises Price Target to $54

9/25/2026
Impact: 70
Healthcare

HC Wainwright & Co. analyst Matthew Caufield has maintained a Buy rating on Surrozen (NASDAQ: SRZN) and increased the price target from $44 to $54.

AI summary, not financial advice

Share: